284 related articles for article (PubMed ID: 32960889)
1. Bifidobacterium animalis subsp lactis HN019 presents antimicrobial potential against periodontopathogens and modulates the immunological response of oral mucosa in periodontitis patients.
Invernici MM; Furlaneto FAC; Salvador SL; Ouwehand AC; Salminen S; Mantziari A; Vinderola G; Ervolino E; Santana SI; Silva PHF; Messora MR
PLoS One; 2020; 15(9):e0238425. PubMed ID: 32960889
[TBL] [Abstract][Full Text] [Related]
2. Effects of Bifidobacterium probiotic on the treatment of chronic periodontitis: A randomized clinical trial.
Invernici MM; Salvador SL; Silva PHF; Soares MSM; Casarin R; Palioto DB; Souza SLS; Taba M; Novaes AB; Furlaneto FAC; Messora MR
J Clin Periodontol; 2018 Oct; 45(10):1198-1210. PubMed ID: 30076613
[TBL] [Abstract][Full Text] [Related]
3. Benefits of Bifidobacterium animalis subsp. lactis Probiotic in Experimental Periodontitis.
Oliveira LF; Salvador SL; Silva PH; Furlaneto FA; Figueiredo L; Casarin R; Ervolino E; Palioto DB; Souza SL; Taba M; Novaes AB; Messora MR
J Periodontol; 2017 Feb; 88(2):197-208. PubMed ID: 27660886
[TBL] [Abstract][Full Text] [Related]
4. Impact of Bifidobacterium animalis subsp. lactis HN019 probiotic in the prevention of periodontitis associated with immunosuppression.
Maia LP; de Almeida Silva Levi YL; Henrique Félix Silva P; Carla Wons L; Pizzo Pitelli L; Goulart de Castro J; da Silva Dólens E; Gregorio D; Gouveia Straioto F; Dos Santos Santinoni C; Casarin R; Ervolino E; Aparecida Chaves Furlaneto F; Reis Messora M
J Periodontol; 2023 Mar; 94(3):389-404. PubMed ID: 36245273
[TBL] [Abstract][Full Text] [Related]
5. Probiotic consumption can modify the resilience of periodontal tissues in rats under experimental periodontitis.
de Oliveira LFF; Silva PHF; Salvador SL; Ervolino E; Casarin R; Figueiredo L; Ricoldi MT; de Souza SLS; Furlaneto F; Messora MR
J Periodontol; 2023 Feb; 94(2):217-229. PubMed ID: 35690993
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral administration of Bifidobacterium animalis subsp. lactis HN019 on the treatment of plaque-induced generalized gingivitis.
de Almeida Silva Levi YL; Ribeiro MC; Silva PHF; Silva GA; de Souza Salvador SL; de Souza SLS; Casarin R; Júnior ABN; Júnior MT; Palioto DB; Honório HM; Messora MR; Furlaneto FAC
Clin Oral Investig; 2023 Jan; 27(1):387-398. PubMed ID: 36305963
[TBL] [Abstract][Full Text] [Related]
7. Effects of the probiotic Bifidobacterium animalis subsp. lactis on the non-surgical treatment of periodontitis. A histomorphometric, microtomographic and immunohistochemical study in rats.
Ricoldi MST; Furlaneto FAC; Oliveira LFF; Teixeira GC; Pischiotini JP; Moreira ALG; Ervolino E; de Oliveira MN; Bogsan CSB; Salvador SL; Messora MR
PLoS One; 2017; 12(6):e0179946. PubMed ID: 28662142
[TBL] [Abstract][Full Text] [Related]
8. Bifidobacterium animalis subsp. lactis as adjunct to non-surgical periodontal treatment in periodontitis: a randomized controlled clinical trial.
Özener HÖ; Kuru L; Kadir T; Kuru B
Clin Oral Investig; 2023 May; 27(5):1965-1972. PubMed ID: 36697840
[TBL] [Abstract][Full Text] [Related]
9. Use of the Probiotic
Araujo LDC; Furlaneto FAC; da Silva LAB; Kapila YL
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012597
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two probiotics in follow-on formula:
Dekker J; Quilter M; Qian H
Benef Microbes; 2022 Oct; 13(4):341-354. PubMed ID: 36004715
[TBL] [Abstract][Full Text] [Related]
11. Effect of Lactobacillus rhamnosus and Bifidobacterium lactis on gingival health, dental plaque, and periodontopathogens in adolescents: a randomised placebo-controlled clinical trial.
Alanzi A; Honkala S; Honkala E; Varghese A; Tolvanen M; Söderling E
Benef Microbes; 2018 Jun; 9(4):593-602. PubMed ID: 29633646
[TBL] [Abstract][Full Text] [Related]
12. Comparison Between Different Delivery Vehicles for the Probiotic Bifidobacterium animalis subsp. lactis HN019 on Experimental Periodontitis in Rats.
Oliveira LFF; da Silva GA; Silva PHF; Moreira ALG; Salvador SL; da Cruz AG; Messora MR; Furlaneto FAC
Probiotics Antimicrob Proteins; 2022 Apr; 14(2):313-325. PubMed ID: 35260963
[TBL] [Abstract][Full Text] [Related]
13. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial.
Ibarra A; Latreille-Barbier M; Donazzolo Y; Pelletier X; Ouwehand AC
Gut Microbes; 2018; 9(3):236-251. PubMed ID: 29227175
[TBL] [Abstract][Full Text] [Related]
14. Effects of
Cardoso RS; Messora MR; Silva PHF; Oliveira LF; Leite-Panissi C; Salvador S; Casarin R; Novaes AB; Palioto DB; Furlaneto FAC
Benef Microbes; 2020 Feb; 11(1):33-46. PubMed ID: 32066256
[TBL] [Abstract][Full Text] [Related]
15. The Influence of a Bifidobacterium animalis Probiotic on Gingival Health: A Randomized Controlled Clinical Trial.
Kuru BE; Laleman I; Yalnızoğlu T; Kuru L; Teughels W
J Periodontol; 2017 Nov; 88(11):1115-1123. PubMed ID: 28753102
[TBL] [Abstract][Full Text] [Related]
16. Bifidobacterium animalis subsp. lactis HN019 has antimicrobial activity against endodontic pathogens in vitro.
Araujo LDC; da Silva RAB; Silva CMPC; Salvador SLS; Messora MR; Furlaneto FAC; Mastrange MDA; Pucinelli CM; da Silva LAB
Braz J Microbiol; 2023 Sep; 54(3):2289-2295. PubMed ID: 37632683
[TBL] [Abstract][Full Text] [Related]
17. Impact of coculturing Bifidobacterium animalis subsp. lactis HN019 with yeasts on microbial viability and metabolite formation.
Toh M; Liu SQ
J Appl Microbiol; 2017 Oct; 123(4):956-968. PubMed ID: 28833937
[TBL] [Abstract][Full Text] [Related]
18. Bifidobacterium animalis subspecies lactis HN019 can reduce the sequelae of experimental periodontitis in rats modulating intestinal parameters, expression of lipogenic genes, and levels of hepatic steatosis.
Moreira ALG; Silva GA; Silva PHF; Salvador SL; Vicente RM; Ferreira GC; Tanus-Santos JE; Mayer MPA; Ishikawa KH; de Souza SLS; Furlaneto FAC; Messora MR
J Periodontal Res; 2023 Oct; 58(5):1006-1019. PubMed ID: 37482954
[TBL] [Abstract][Full Text] [Related]
19. Impact of orally administered lozenges with Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis BB-12 on the number of salivary mutans streptococci, amount of plaque, gingival inflammation and the oral microbiome in healthy adults.
Toiviainen A; Jalasvuori H; Lahti E; Gursoy U; Salminen S; Fontana M; Flannagan S; Eckert G; Kokaras A; Paster B; Söderling E
Clin Oral Investig; 2015 Jan; 19(1):77-83. PubMed ID: 24638207
[TBL] [Abstract][Full Text] [Related]
20. Periodontopathogens and human β-defensin-2 expression in gingival crevicular fluid from patients with periodontal disease in Guangxi, China.
Yong X; Chen Y; Tao R; Zeng Q; Liu Z; Jiang L; Ye L; Lin X
J Periodontal Res; 2015 Jun; 50(3):403-10. PubMed ID: 25065393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
